cpass neutralization antibody detection kit (GenScript corporation)
90
Structured Review
GenScript corporation
cpass neutralization antibody detection kit
Cpass Neutralization Antibody Detection Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/genscript+cpass+kit/cpass+neutralization+antibody+detection+kit/pmc08701648-9-6-11
Average 90 stars, based on 1 article reviews
Cpass Neutralization Antibody Detection Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/genscript+cpass+kit/cpass+neutralization+antibody+detection+kit/pmc08701648-9-6-11
Average 90 stars, based on 1 article reviews
cpass neutralization antibody detection kit - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Virus:Article Title: Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022 Article Snippet: Most (96.8%, n = 4634) of the positive specimens received until April 2021 were frozen at −30 °C and additionally analysed in a plaque reduction neutralisation assay (PRNT) ( n = 647) and/or a surrogate virus neutralisation test (sVNT) ( n = 4246) targeting the Angiotensin Converting Enzyme (ACE) 2 receptor binding domain of the SARS-CoV-2 spike protein (cPassTM Neutralization Antibody Detection Kit, Genscript Biotech, Piscataway Township, NJ, USA). .. A subset of 379 N-positive specimens collected in 2022 was analysed with discriminatory sVNT targeting the wild-type virus or the Omicron variant ( Article Title: Relative role of border restrictions, case finding and contact tracing in controlling SARS-CoV-2 in the presence of undetected transmission: a mathematical modelling study. Article Snippet: .. Serology was performed using commercially available test kits from Roche, Wondfo and GenScript Article Title: Relative role of border restrictions, case finding and contact tracing in controlling SARS-CoV-2 in the presence of undetected transmission: a mathematical modelling study Article Snippet: .. Serology was performed using commercially available test kits from Roche, Wondfo and GenScript Article Title: Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial. Article Snippet: .. Surrogate virus neutralization test Concentrated BALF neutralizing antibodies were assessed utilizing a surrogate SARS-CoV-2 virus neutralization test (sVNT). sVNT assays were performed utilizing the Article Title: Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial Article Snippet: .. Concentrated BALF neutralizing antibodies were assessed utilizing a surrogate SARS-CoV-2 virus neutralization test (sVNT). sVNT assays were performed utilizing the Variant Assay:Article Title: Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022 Article Snippet: Most (96.8%, n = 4634) of the positive specimens received until April 2021 were frozen at −30 °C and additionally analysed in a plaque reduction neutralisation assay (PRNT) ( n = 647) and/or a surrogate virus neutralisation test (sVNT) ( n = 4246) targeting the Angiotensin Converting Enzyme (ACE) 2 receptor binding domain of the SARS-CoV-2 spike protein (cPassTM Neutralization Antibody Detection Kit, Genscript Biotech, Piscataway Township, NJ, USA). .. A subset of 379 N-positive specimens collected in 2022 was analysed with discriminatory sVNT targeting the wild-type virus or the Omicron variant ( Neutralization:Article Title: Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022 Article Snippet: Most (96.8%, n = 4634) of the positive specimens received until April 2021 were frozen at −30 °C and additionally analysed in a plaque reduction neutralisation assay (PRNT) ( n = 647) and/or a surrogate virus neutralisation test (sVNT) ( n = 4246) targeting the Angiotensin Converting Enzyme (ACE) 2 receptor binding domain of the SARS-CoV-2 spike protein (cPassTM Neutralization Antibody Detection Kit, Genscript Biotech, Piscataway Township, NJ, USA). .. A subset of 379 N-positive specimens collected in 2022 was analysed with discriminatory sVNT targeting the wild-type virus or the Omicron variant ( Article Title: Relative role of border restrictions, case finding and contact tracing in controlling SARS-CoV-2 in the presence of undetected transmission: a mathematical modelling study. Article Snippet: .. Serology was performed using commercially available test kits from Roche, Wondfo and GenScript Article Title: Temporal correlations between RBD-ACE2 blocking and binding antibodies to SARS-CoV-2 variants in CoronaVac-vaccinated individuals and their persistence in COVID-19 patients Article Snippet: .. A previous study reported a strong correlation between nAb levels measured using a Article Title: Relative role of border restrictions, case finding and contact tracing in controlling SARS-CoV-2 in the presence of undetected transmission: a mathematical modelling study Article Snippet: .. Serology was performed using commercially available test kits from Roche, Wondfo and GenScript Article Title: Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial. Article Snippet: .. Surrogate virus neutralization test Concentrated BALF neutralizing antibodies were assessed utilizing a surrogate SARS-CoV-2 virus neutralization test (sVNT). sVNT assays were performed utilizing the Article Title: Temporal correlations between RBD-ACE2 blocking and binding antibodies to SARS-CoV-2 variants in CoronaVac-vaccinated individuals and their persistence in COVID-19 patients. Article Snippet: .. A previous study reported a strong correlation between nAb levels measured using a Article Title: Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial Article Snippet: .. Concentrated BALF neutralizing antibodies were assessed utilizing a surrogate SARS-CoV-2 virus neutralization test (sVNT). sVNT assays were performed utilizing the Generated:Article Title: Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus Article Snippet: .. Using these values, we were able to calculate that hAd5 S-Fusion+N-ETSD vaccination generated a geometric mean value of 5.8 S-specific IgG and 42 μg N-specific IgG per milliliter of serum. cPassTM Neutralizing Blocking Assay:Article Title: Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus Article Snippet: .. Using these values, we were able to calculate that hAd5 S-Fusion+N-ETSD vaccination generated a geometric mean value of 5.8 S-specific IgG and 42 μg N-specific IgG per milliliter of serum. cPassTM Neutralizing Cell Surface Receptor Assay:Article Title: Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus Article Snippet: .. Using these values, we were able to calculate that hAd5 S-Fusion+N-ETSD vaccination generated a geometric mean value of 5.8 S-specific IgG and 42 μg N-specific IgG per milliliter of serum. cPassTM Neutralizing |
